Search peptides, terms, sources/
Research source · 2025

Effect of abaloparatide on fracture incidence and bone mineral density in postmenopausal women with osteoporosis at highest risk for fracture

About this source

Kind
Research
Design
Human clinical trial, Human observational
Population
Subgroup of ACTIVE trial participants at highest fracture risk
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 November 2026

Limitations

Post hoc subgroup analysis of the ACTIVE trial. Subgroup results are less reliable than the primary analysis. The abstract record read reports no hazard ratios.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.